title: Promotion of early osteoclastogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I.
abstract: Human T-cell lymphotropic virus type I (HTLV-I) is associated with various clinical disorders including adult T cell leukemia, myelopathy, arthropathy. Hypercalcemia resulting from osteoclast activation and a variety of hematopoietic abnormalities have been also observed in HTLV-I infected patients, however, precise mechanism about initial trigger(s) prior to presenting symptoms is still unknown. In this study, to assess effects of HTLV-I on hematopoiesis, we analysed characteristics of early hematopoietic precursors in HTLV-I env-pX transgenic rats. Progenitor cells for osteoclasts were significantly increased even in the marrow of asymptomatic env-pX rats. Progenitors for B cells were also highly enriched, while colony forming cells (CFC) elicited by GM-CSF(CFU-GM) and M-CSF(CFU-M) were comparable to normal littermates. Following arthritis in env-pX transgenic rats, osteoclastogenesis was further augmented and the CFCs were increased. Bone marrow cells carrying adjuvant-induced arthritis retained a constant number of progenitors for osteoclast and B lymphocytes, whereas the number of CFU-GM and CFU-M increased. These results indicate that the env-pX transgene affect early stages of osteoclast and B-cell lineages prior to developing diseases, in contrast, an increase of the CFCs was caused indirectly by arthritis. This study provides a novel standpoint for the mechanisms of pathogenesis by HTLV-I.
authors.affiliation: Department of Immunology, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Yamazaki
authors.forename: T
authors.initials: T
authors.lastname: Kunisada
authors.forename: A
authors.initials: A
authors.lastname: Ishizu
authors.forename: H
authors.initials: H
authors.lastname: Ikeda
authors.forename: I
authors.initials: I
authors.lastname: Miyoshi
authors.forename: T
authors.initials: T
authors.lastname: Sudo
authors.forename: S I
authors.initials: SI
authors.lastname: Hayashi
authors.forename: T
authors.initials: T
authors.lastname: Yoshiki
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D001169:Arthritis, Experimental; D001402:B-Lymphocytes / Q000166:cytology*; D001854:Bone Marrow Cells / Q000166:cytology*; D002454:Cell Differentiation; D002478:Cells, Cultured; D005620:Freund's Adjuvant / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D019891:Leukopoiesis; D008297:Male; D010006:Osteoblasts / Q000166:cytology*; D051381:Rats; D011917:Rats, Inbred Lew; D017208:Rats, Wistar; D015682:Retroviridae Proteins, Oncogenic / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D054334:Viral Regulatory and Accessory Proteins
chemical_list: D015682:Retroviridae Proteins, Oncogenic; D014157:Transcription Factors; D014759:Viral Envelope Proteins; D054334:Viral Regulatory and Accessory Proteins; C072343:pX protein, Human T-lymphotropic virus 1; D005620:Freund's Adjuvant